At any time Memorial Sloan-Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.
The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.
| Title |
Investigator |
Disease(s) |
|---|---|---|
|
A Phase I Study of TRC105 plus Bevacizumab in Patients with Recurrent Glioma [Protocol 12-217] |
Omuro, Antonio |
|
|
A Phase II Study of Carboplatin and Bevacizumab for the Treatment of Recurrent Low-Grade and Anaplastic Ependymoma in Adults [Protocol 11-146] |
Omuro, Antonio |
|
|
A Phase II Study of Dose-Dense Temozolomide and Lapatinib for Recurrent Low- Grade and Anaplastic Ependymoma [Protocol 09-031] |
Omuro, Antonio |
|
|
Glioma International Case-Control Study [Protocol 10-073] |
Olson, Sara |
|
|
Melanoma Survivors: Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns [Protocol 06-128] |
Oliveria, Susan |
|
|
Collection of Saliva Samples for Genetic Epidemiology Studies of Cancer and Aging [Protocol 06-102] |
Offit, Kenneth |
|
|
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders [Protocol 00-069] |
Offit, Kenneth |
|
|
Analysis of Blood and Salivary Samples for Genetic Studies of Familial Cancers [Protocol 93-102] |
Offit, Kenneth |
|
|
Clinical Significance of Germline BRCA Mutations [Protocol 96-051] |
Offit, Kenneth |
|
|
EMPOWER Study: Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer [Protocol 10-104] |
Oeffinger, Kevin |
|
|
A Phase I Study of WT1-Sensitized T cells for Residual or Relapsed Leukemia after Allogeneic Hematopoietic Progenitor Cell Transplantation [Protocol 07-055] |
O'Reilly, Richard |
|
|
A Phase II Study Evaluating the Use of Donated EBV-Immune T Cells to Treat Transplant Recipients with EBV [Protocol 11-130] |
O'Reilly, Richard |
|
|
A Phase II Study of CMV-Immune T cells for the Treatment of Cytomegalovirus Infection after Stem Cell Transplantation [Protocol 12-086] |
O'Reilly, Richard |
|
|
A Phase I/II Study of the Toxic and Therapeutic Effects of T Cells in the Treatment of Epstein Barr Virus-Associated Lymphoproliferative Disorders [Protocol 95-024] |
O'Reilly, Richard |
|
|
A Prospective Natural History Study of the Diagnosis, Treatment, and Outcomes of Children with SCID Disorders [Protocol 10-150] |
O'Reilly, Richard |
|
|
Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLA-Compatible Donor [Protocol 12-053] |
O'Reilly, Richard |
|
|
A Phase II Trial of Transplants from HLA-Compatible Donors with T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System for the Treatment of Patients with Hematologic Malignancies and Disorders [Protocol 10-050] |
O'Reilly, Richard |
|
|
Two Phase II Studies of Veliparib for Pancreatic Cancer with a BRCA or PALB2 Mutation: Gemcitabine & Cisplatin with/without Veliparib in Untreated Pancreatic Cancer (Part I) & Veliparib Alone for Patients with Previously Treated Pancreatic Cancer (Part II [Protocol 12-045] |
O'Reilly, Eileen |
|
|
A Phase I/II Study of M402 in Combination with Gemcitabine in Patients with Previously Untreated Metastatic Pancreatic Cancer [Protocol 12-078] |
O'Reilly, Eileen |
|
|
A Phase IB/II Study of OMP-59R5 with Gemcitabine in Patients with Previously Untreated Metastatic Pancreatic Cancer [Protocol 12-234] |
O'Reilly, Eileen |
|
